4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0000950170-24-074907
Options or other derivatives
- Director acquired 47,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BAKER BROS. ADVISORS LP Director | 2024-06-14 | Grant or award · Non- Qualified Stock Option (right to buy) | +23,500 | 23,500 | I | ||
| BAKER BROS. ADVISORS LP Director | 2024-06-14 | Grant or award · Non- Qualified Stock Option (right to buy) | +23,500 | 23,500 | I | ||
Loading xslF345X05/ownership.xml…